Three loci modify growth of a transgene-induced mammary tumor: Suppression of proliferation associated with decreased microvessel density

Genomics

Volumn 74, Issue 3, 2001, Pages 253-261

  Le Voyer, Tom ^a   Rouse, Jessica ^b   Lu, Zichun ^a   Lifsted, Traci ^a   Williams, Max ^a   Hunter, Kent W ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; ENDOSTATIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY; GENE LOCUS; GENE MAPPING; MICROVASCULATURE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALIA;

EID: 0035874937     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2001.6562     Document Type: Article

References (37)

1. Mitotic indexes as prognostic predictors in female breast cancer
2. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymphnode-positive breast cancer
3. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: High frequency of chromosome 4 loss of heterozygosity at advanced stages of progression
4. Relationships between vascularization and proliferation in invasive breast cancer
5. Genetic alterations in breast cancer
6. The Mouse Genome Database (MGD): Expanding genetic and genomic resources for the laboratory mouse
7. Implications of growth rate for the management of cancer
8. Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice
9. Somatic genetic changes in human breast cancer
10. Permutation tests for multiple loci affecting a quantitative character
11. Location of several putative genes possibly involved in human breast cancer progression
12. Taking stock of complex trait genetics in mice
13. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki- 67 antibodies: Its prognostic value on short-term recurrences
14. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice
15. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease
16. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: Correlation with 5-bromo-2′-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis
17. The cross rates of growth of human mammary carcinoma
18. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
19. An epistatic interaction controls the latency of a transgene-induced mammary tumor
20. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression
21. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival
22. Overview of QTL mapping software and introduction to map manager QT
23. Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase
24. Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma
25. Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling
26. Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptors
27. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
28. Angiostatin: A circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth
29. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
30. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice
31. Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4
32. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice
33. The prognostic value of measuring the gross linear radial growth of pulmonary metastases and primary pulmonary cancers
34. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice
35. Apoptosis and angiogenesis: Two promising tumor markers in breast cancer
36. Apolipoprotein E polymorphism and central nervous system tumors: Correlation with cell proliferation indices and clinical outcome